Metraipolis › archive › dc_8e8b6026d7e2
Efficacy and safety of tislelizumab in patients with advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis — Europe PMC PMID:40850957
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40850957
- DOI
- 10.1186/s43046-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T09:35:21.916Z
- SHA-256 of the archived text
73a0c47a83c1332a0a93abfdb0af3918bfd33ca011e3ebf7a5da306bdae854ea- Stable URL of this page
https://metraipolis.com/documento/dc_8e8b6026d7e2
How to cite
Efficacy and safety of tislelizumab in patients with advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis — Europe PMC PMID:40850957 — Europe PMC (en), https://europepmc.org/article/MED/40850957 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8e8b6026d7e2 (Metraipolis archive dc_8e8b6026d7e2, sha256 73a0c47a83c1332a0a93abfdb0af3918bfd33ca011e3ebf7a5da306bdae854ea)
BibTeX
@misc{dc8e8b6026d7e2,
title = {Efficacy and safety of tislelizumab in patients with advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis — Europe PMC PMID:40850957},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40850957},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8e8b6026d7e2; sha256 73a0c47a83c1332a0a93abfdb0af3918bfd33ca011e3ebf7a5da306bdae854ea},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40850957. Agents can read the archived copy with the MCP tool read_document.